Table 3.
Outcome measurements at each timepoint
Measurements | Baseline | Treatment phase | Follow-up phase | ||||||
−4 weeks | 0 week | 2 weeks | 4 weeks | 8 weeks | 12 weeks | 16 weeks | 20 weeks | 24 weeks | |
Measurements of pressure-pain threshold | × | × | × | ||||||
VAS | × | × | × | × | × | × | × | × | |
NPQ | × | × | × | × | × | × | × | ||
MPQ | × | × | × | × | × | × | × | ||
SF-12 | × | × | × | × | × | × | × | ||
NDI | × | × | × | × | × | × | × | ||
CROM | × | × | |||||||
SAS | × | × | × | × | × | × | × | ||
SDS | × | × | × | × | × | × | × | ||
Adverse events | × | × | × | × | × | × | × | × |